Corticosteroid-Induced Multifocal and Extensive Lipomatosis: A Case Report

Ilham Bouaddi, Hanan Rkain, Fadoua Allali, Nazik Allali, Najia Hajjaj-Hassouni

.

DOI: 10.4236/ojpathology.2011.11001                

Abstract

Introduction: Corticosteroid-induced lipomatosis are uncommon situation. We report a case of an extensive lipomatosis in a rheumatoid arthritis patient, who received a long term steroid therapy. Case report: A 49-year-old rheumatoid arthritis woman, who received for two years a mean dose of 15 mg/ day of prednisone equivalent, was admitted to the hospital for a six months history of progressive abdominal distension and dyspnea. Physical exam revealed typical symptoms of Cushing’s syndrome and an important increase of abdominal volume. Lipomatosis diagnosis with mesenteric, mediastinal, retroperitoneal and epidural localizations, was rapidly confirmed by sonography and computed tomography (CT) exams. Management was based on corticosteroid reduction as well as use of hygiene and dietary measures. Therapeutic efficacy was noted on a clinical basis within one year. Discussion: lipomatosis occurs as a less known complication of long-term steroid therapy. Its localizations are numerous. Epidural and mediastinal lipomatosis are more frequent than mesenteric or retroperitoneal ones. Most frequently asymptomatic, lipomatosis could sometimes be revealed by false symptoms. Medical treatment including corticosteroid with drawal or reduction and calorie restriction, can lead to clinical improvement. Surgery is reseved in advanced forms with serious complications.

Keywords

Lipomatosis, Mesenteric, Retroperitoneal, Mediastinal, Epidural, Corticosteroids

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	S. Humblot, J. C. Weber, A. S. Korganow, B. Hammann, J. L. Pasquali and T. Martin, “Les Lipomatoses Induites par la Corticothérapie,” La Revue de Médecine Interne, Vol. 18, No. 5, 1997, pp. 396-401.
[2]	L. Dujardin, C. Marcelli, C. Hérisson and L. Simon, “La Lipo-Matose Epidurale: Une Complication de la Cortico- thérapie au Long Court, Apropos de Deux Cas,” La Revue de Médecine Interne, Vol. 17, No. 7, 1996, pp. 563-567.
[3]	G. R. Fogel, “Cunningham PY 3rd, Esses SI. Spinal Epidural Lipomatosis: Case Reports, Literature Review and Metaanalysis,” Spine Journal, Vol. 5, No. 2, 2005, pp. 202-211.
[4]	K. Q. Nguyen, C. Hoeffel, L. H. Le and H. T. Phan, “Me- diastinal Lipomatosis,” South Medecine Journal, Vol. 91, 1998, pp. 1169-1172.
[5]	J. Hierholzer, G. Bendorf, T. Lehmann, G. H. Schneider, P. Podrabski, B. Sander, et al., “Epidural Lipomatosis: Case Report and Literature Review,” Neuroradiology, Vol. 38, No. 4, 1996, pp. 343-348.
[6]	F. Laroche, P. Chemouilli, R. Carlier, D. Doyon and G. “Sa?d Efficacité du Traitement Médical dans une Com- pression Médullaire par Lipomatose Epidurale Compli- quant une Corticothérapie Prolongée,” Rev Rhum Ed Fr, Vol. 60, No. 11, 1993, pp. 846-849.
[7]	W. E. George Jr, M. Wilmot, A. Greenhouse and M. Ham- meke, “Medical Management of Steroid-Induced Epi- dural Lipomatosis,” The New England Journal of Medi- cine, Vol. 308, No. 6, 1983, pp. 316-319. doi:10.1056/NEJM198302103080605
[8]	V. Gilsanz, P. W. Brill, B. S. Wolf, “Increased Retroperi- toneal Fat: A Sign of Corticosteroid Therapy,” Radiology, Vol. 123, 1977, pp. 147-148.
[9]	M. Domínguez Domínguez, J. E. Camacho Gonzalez, A. Palacios Martinez, J. M. Gonzalez Montano, R. Quintero Rodriguez and R. Ibanez Suarez, “Pelvic Lipomatosis: Cause of Bladder Rupture,” Actas Urologicsa Espanolas, Vol. 25, No. 8, 2001, pp. 592-595.
[10]	A. H. Zargar, B. A. Laway, S. R. Masoodi, M. H. Bhat, M. I. Bashir, A. I. Wani and N. A. Wani, “Diffuse Abdominal Lipomatosis,” The Journal of The Association of Physicians India, Vol. 51, 2003, pp. 621-622.